Citizen Health Partner to Support Drug Development and Long-Term Patient Outcomes in PKP2 Cardiomyopathy
Citizen Health today announced a strategic partnership to support Rocket Pharmaceutical Inc.’s (Rocket Pharma) clinical and long-term data initiatives for arrhythmogenic cardiomyopathy (ACM) caused by mutations in the PKP2 gene. PKP2-ACM...

